In a draft report issued December 28, 2018 by the US Department of Health and Human Services-sponsored Pain Management Best Practices Inter-Agency Task Force, recommendations for a multidisciplinary approach to pain management were formulated.
The American College of Rheumatology and the National Psoriasis Foundation have released 2018 joint recommendations for the treatment of psoriatic arthritis.
A recent systematic review found that nurse-led care is effective, acceptable, and safe in patients with rheumatoid arthritis.
The guideline formulated by the Centers for Disease Control and Prevention in an effort to curb opioid overdose-related deaths included a recommendation for steep reductions in opioid doses for patients taking high doses of the drug for chronic pain.
Eligibility criteria employed in clinical trials assessing pharmacologic treatment of bipolar disorder typically preclude many affected patients, casting doubt about the generalizability of their results.
Patients with rheumatoid arthritis often use natural-product dietary supplements, but few disclose this to their healthcare providers.
Despite concerns that the digital revolution in psychiatry might lessen the importance of interpersonal relationships between patient and clinician, digital apps have the potential to make the therapeutic alliance even more powerful.
Divergent recommendations in guidelines from the USPSTF and the ATA/AACE contribute to the controversy surrounding whether to test and treat for subclinical hypothyroidism.
A 4-fold increase has been seen in pre-treatment HIV drug resistance in children with prenatal exposure to ART.
